160 likes | 305 Views
Region II IPP Data & Infrastructure Performance Measures. Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc. Region II IPP Workplan, 2006-2007.
E N D
Region II IPP Data & Infrastructure Performance Measures Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
Region II IPP Workplan, 2006-2007 • PRIORITY 2: Incorporate Analysis of Regional Prevalence Monitoring Data for Regional and Local Data-Directed Planning and Quality Assurance • GOAL: IPP data will direct the most cost effective implementation of screening and treatment funds. • OBJECTIVE 2B: Identify what percentage of eligible women are being screened on an annual basis among select sites participating in the Region II IPP.
Region II IPP2005 Screening “Audit” Purpose: • Estimate chlamydia screening coverage among eligible female patients according to Region II IPP minimum screening criteria • Pilot regional methodology for assessing screening coverage and adherence to screening criteria in anticipation of CDC proposed measures of effectiveness
Region II IPPMinimum Screening Criteria Title X Family Planning Clinics • All women ≤ 24 years of age attending the clinic for an initial or annual visit will be screened for chlamydia. STD Clinics • All women ≤ 29 years of age attending the STD clinic will be screened for chlamydia.
Implications/Discussion • Region II IPP minimum screening criteria for FP include only those women who have an initial or annual (i.e. pelvic) exam • In the past, chlamydia testing required the collection of a cervical specimen. • Highly-sensitive urine-based NAATs (nucleic acid amplification tests) provide an opportunity for expanded screening to additional high-risk clients.
Percent of Ct Tests Reported as NAATRegion II IPP, 2004-2006
Current Use of Urine Specimen forCt Testing Among FemalesRegion II IPP, CY2005
Current Use of Urine Specimen forCt Testing Among FemalesRegion II IPP, CY2006
Region II IPPStrategic Plan 2005-2009 • PRIORITY 1: Target/Expand Chlamydia Screening to Young Sexually Active Women and Men at Risk for Infection in Public and Private Settings. • GOAL: All at risk men and women under the age of 25 will be screened at least annually. • OBJECTIVE 1C: By December 2007, decrease routine CT and GC screening by 50% in women >30 years of age in FP clinics where the prevalence of CT is less than 2%.
Screening Trends inFP Clinics, Region II IPP N (2003) = 46,077 22,691 41,609 4,684 2,030 117,091 N (2004) = 36,825 21,995 26,050 6,503 2,019 93,392 N (2005) = 47,542 20,871 95,957 7,054 966 172,390 N (2006) = 48387 14,388 101,880 6,710 800 172,165
Chlamydia Positivity Among Females Age 30+ Yrs in FP Clinics
2007 Regional IPP Infrastructure Performance Measures Measure 1: Screening Coverage in FP Proportion of female Family Planning users screened for chlamydia, by age group • Data Source: FPAR Tables 1 & 11 Measure 2: Test Utilization Proportion of chlamydia tests conducted on females, stratified by age group • Data Source: IPP Prevalence Monitoring Data
IPP Infrastructure PM 1:Estimated Ct Screening Coverage Proportion of Female Family Planning Users Screened for Chlamydia, by Age Group, 2006 FPAR